ScreenerHero

ILA Island Pharmaceuticals Limited

ASX · AU · Healthcare · Biotechnology · islandpharmaceuticals.com
—Mkt Cap: —P/E: —

Island Pharmaceuticals Limited, a drug repurposing company, focuses on the development of antiviral therapeutics for infectious diseases in Australia and the United States. The company's lead product candidate is ISLA-10…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.87BUSDP/E 29.6
MRNA
Moderna, Inc.
$94.42BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$81.99BUSDP/E 19.1
ARGX
argenx SE
$53.47BUSDP/E 32.5
ARGX
argenx SE
$53.22BUSDP/E 31.6
UCB
UCB SA
$44.02BUSDP/E 17.8
ONC
BeOne Medicines AG
$42.56BUSDP/E 66.4
RVMD
Revolution Medicines, Inc.
$40.57BUSD
RPRX
Royalty Pharma plc
$34.45BUSDP/E 30.4
ALNY
Alnylam Pharmaceuticals, Inc.
$31.32BUSDP/E 39.3
ROIV
Roivant Sciences Ltd.
$24.59BUSD
GMAB
Genmab A/S
$23.32BUSDP/E 31.7
GMAB
Genmab A/S
$23.26BUSDP/E 29.8
INCY
Incyte Corporation
$22.96BUSDP/E 14.0
BNTX
BioNTech SE
$22.66BUSD
INSM
Insmed Incorporated
$21.67BUSD
EXEL
Exelixis, Inc.
$15.57BUSDP/E 19.3
ASND
Ascendis Pharma A/S
$14.91BUSDP/E 17.4
JAZZ
Jazz Pharmaceuticals plc
$13.92BUSDP/E 14.7
HALO
Halozyme Therapeutics, Inc.
$13.79BUSDP/E 33.4

Key Statistics

Company
Market Cap—
Enterprise Value60.64M USD
Revenue (TTM)195.34K USD
Gross Profit195.34K USD
Net Income (TTM)-6.80M USD
Revenue/Share0.0010 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryBiotechnology
ISINAU0000138869
Valuation
P/E (Trailing)—
P/E (Forward)0.26
PEG—
EV/EBITDA-8.58
EV/Revenue310.41
P/S355.95
P/B7.56
EPS (TTM)-0.03
EPS (Forward)1.28
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin100.00%
Oper. Margin-2240.47%
EBITDA Margin0.00%
Profit Margin-3482.66%
ROE-73.15%
ROA-70.33%
Growth
Revenue Growth996.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.34M USD
CapEx (TTM)581.69K USD
FCF Margin-738.74%
FCF Yield—
Net Debt-8.90M USD
Net Debt/EBITDA1.26
Balance Sheet
Debt/Equity—
Current Ratio24.62
Quick Ratio24.43
Book Value/Sh0.04 AUD
Cash/Share0.04 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating0.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)1.600 AUD
Target Range1.600 AUD – 1.600 AUD
# Analysts1
Ownership
Shares Out.295.92M
Float164.86M
Insiders50.76%
Institutions0.00%
Technical
SMA 500.4230 AUD
SMA 2000.4012 AUD
Beta0.17
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)299.38K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—